Published in Clin Exp Allergy on August 01, 2011
Primary Prevention of Allergic Disease in Early Child by Lactobacillus Reuteri | NCT01285830
Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and meta-analysis. BMJ (2013) 1.67
The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health Dis (2015) 1.33
Asthma and atopy in children born by caesarean section: effect modification by family history of allergies - a population based cross-sectional study. BMC Pediatr (2012) 0.95
Airway epithelial SPDEF integrates goblet cell differentiation and pulmonary Th2 inflammation. J Clin Invest (2015) 0.92
Severe viral respiratory infections: are bugs bugging? Mucosal Immunol (2013) 0.90
Elevated serum levels of macrophage-derived chemokine and thymus and activation-regulated chemokine in autistic children. J Neuroinflammation (2013) 0.83
Human colostrum oligosaccharides modulate major immunologic pathways of immature human intestine. Mucosal Immunol (2014) 0.81
T-helper1/T-helper2 cytokine imbalance in the iris of patients with glaucoma. PLoS One (2015) 0.80
Developmental programming for allergy: a secondary analysis of the Mothers, Omega-3, and Mental Health Study. Am J Obstet Gynecol (2013) 0.78
Identifying CpG sites associated with eczema via random forest screening of epigenome-scale DNA methylation. Clin Epigenetics (2015) 0.78
Human Milk Components Modulate Toll-Like Receptor-Mediated Inflammation. Adv Nutr (2016) 0.78
The quest for predictive immune biomarkers. Clin Exp Allergy (2011) 0.78
Relationship between periodontal disease and asthma among overweight/obese adults. J Clin Periodontol (2016) 0.77
Picornavirus-Induced Airway Mucosa Immune Profile in Asymptomatic Neonates. J Infect Dis (2015) 0.75
Early life exposure to environmental tobacco smoke alters immune response to asbestos via a shift in inflammatory phenotype resulting in increased disease development. Inhal Toxicol (2016) 0.75
High cord blood CCL22/CXCL10 chemokine ratios precede allergic sensitization in early childhood. Oncotarget (2016) 0.75
Prophylactic Supplementation of Bifidobacterium longum 5(1A) Protects Mice from Ovariectomy-Induced Exacerbated Allergic Airway Inflammation and Airway Hyperresponsiveness. Front Microbiol (2017) 0.75
The cytotoxic protein YopE of Yersinia obstructs the primary host defence. Mol Microbiol (1990) 5.09
Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption. Infect Immun (1991) 4.46
Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87
A secreted protein kinase of Yersinia pseudotuberculosis is an indispensable virulence determinant. Nature (1993) 3.40
Analysis of the V antigen lcrGVH-yopBD operon of Yersinia pseudotuberculosis: evidence for a regulatory role of LcrH and LcrV. J Bacteriol (1991) 3.32
Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics (1995) 2.87
Symptoms of bronchial hyperreactivity and asthma in relation to environmental factors. Arch Dis Child (1988) 2.47
Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments. Mol Microbiol (1997) 2.40
The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation. Mol Microbiol (1999) 2.37
Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods. Eur Respir J (2004) 2.36
Functional conservation of the secretion and translocation machinery for virulence proteins of yersiniae, salmonellae and shigellae. EMBO J (1995) 2.30
Hydrolysed cow's milk formulae. Allergenicity and use in treatment and prevention. An ESPACI position paper. European Society of Pediatric Allergy and Clinical Immunology. Pediatr Allergy Immunol (1993) 2.17
Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15
A novel protein, LcrQ, involved in the low-calcium response of Yersinia pseudotuberculosis shows extensive homology to YopH. J Bacteriol (1992) 2.11
Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis. Infect Immun (1979) 2.08
Identification and mapping of the temperature-inducible, plasmid-encoded proteins of Yersinia spp. Infect Immun (1988) 1.90
Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy (1999) 1.86
Bacterial evasion of host immune defense: Yersinia enterocolitica encodes a suppressor for tumor necrosis factor alpha expression. Infect Immun (1995) 1.85
Interaction of E. coli strains with human serum: lack of relationship to K1 antigen. J Pediatr (1976) 1.83
Endotoxin levels in Estonian and Swedish house dust and atopy in infancy. Clin Exp Allergy (2003) 1.79
YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane. Mol Microbiol (1997) 1.74
The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three. Clin Exp Allergy (2013) 1.72
The chaperone-like protein YerA of Yersinia pseudotuberculosis stabilizes YopE in the cytoplasm but is dispensible for targeting to the secretion loci. Mol Microbiol (1995) 1.64
International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax (2000) 1.64
Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clin Exp Allergy (2009) 1.61
Atopic versus infectious diseases in childhood: a question of balance? Pediatr Allergy Immunol (1997) 1.60
Cord blood levels of immunoglobulin G subclass antibodies to food and inhalant allergens in relation to maternal atopy and the development of atopic disease during the first 8 years of life. Clin Exp Allergy (2000) 1.58
Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clin Exp Allergy (2009) 1.58
Comparison of asthma prevalence in the ISAAC and the ECRHS. ISAAC Steering Committee and the European Community Respiratory Health Survey. International Study of Asthma and Allergies in Childhood. Eur Respir J (2000) 1.57
Atopy and allergic disorders among adults in Tartu, Estonia compared with Uppsala, Sweden. Clin Exp Allergy (1998) 1.50
Interaction of human serum and neutrophils with Escherichia coli strains: differences between strains isolated from urine of patients with pyelonephritis or asymptomatic bacteriuria. Infect Immun (1978) 1.50
Thymus size and head circumference at birth and the development of allergic diseases. Clin Exp Allergy (2001) 1.48
Functional conservation of the effector protein translocators PopB/YopB and PopD/YopD of Pseudomonas aeruginosa and Yersinia pseudotuberculosis. Mol Microbiol (1998) 1.47
Diet and asthma, allergic rhinoconjunctivitis and atopic eczema symptom prevalence: an ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. ISAAC Phase One Study Group. Eur Respir J (2001) 1.46
PHA-induced IL-12R beta(2) mRNA expression in atopic and non-atopic children. Clin Exp Allergy (2001) 1.44
Cord blood Th2-related chemokine CCL22 levels associate with elevated total-IgE during preschool age. Clin Exp Allergy (2012) 1.44
Immune responses to birch in young children during their first 7 years of life. Clin Exp Allergy (2002) 1.43
Local immunotherapy is not documented for clinical use. Allergy (1994) 1.43
Fatty acid composition in colostrum and mature milk from non-atopic and atopic mothers during the first 6 months of lactation. Acta Paediatr (1998) 1.42
Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy (2014) 1.41
Virulence plasmid-encoded YopK is essential for Yersinia pseudotuberculosis to cause systemic infection in mice. Infect Immun (1995) 1.36
Microflora-associated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy (2000) 1.35
Construction of a reporter plasmid for screening in vivo promoter activity in Francisella tularensis. FEMS Microbiol Lett (2001) 1.32
The chemiluminescence response and bactericidal activity of polymorphonuclear neutrophils from newborns and their mothers. Pediatrics (1979) 1.30
How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. Br J Dermatol (2009) 1.30
A randomized controlled trial of the effect of pertussis vaccines on atopic disease. Arch Pediatr Adolesc Med (1998) 1.29
Murine toxin of Yersinia pestis shows phospholipase D activity but is not required for virulence in mice. Int J Med Microbiol (2000) 1.28
Adverse reactions to food. European Academy of Allergology and Clinical Immunology Subcommittee. Allergy (1995) 1.26
Collecting and banking human milk: to heat or not to heat? Br Med J (1980) 1.25
Inhibition of human neutrophil chemotaxis and chemiluminescence by amphotericin B. Infect Immun (1976) 1.25
Interaction of Escherichia coli with different fimbriae and polymorphonuclear leukocytes. Infect Immun (1982) 1.23
The relationship between body mass and oxygen uptake during running in humans. Med Sci Sports Exerc (1991) 1.22
Chronic recurrent multifocal osteomyelitis and pustulosis palmoplantaris. J Pediatr (1978) 1.19
Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children. Clin Exp Allergy (2005) 1.19
Pustulosis palmoplantaris and its relation to chronic recurrent multifocal osteomyelitis. Dermatologica (1979) 1.17
Increased IgE antibody responses in rats exposed to tobacco smoke. J Allergy Clin Immunol (1985) 1.16
Cytokines in breast milk from allergic and nonallergic mothers. Pediatr Res (2000) 1.15
Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood. Am J Public Health (2001) 1.14
Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Arch Dis Child (1997) 1.14
An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). J Allergy Clin Immunol (2000) 1.13
The precision of the conjunctival provocation test. Allergy (1984) 1.13
The prevalence of allergy and IgE antibodies to inhalant allergens in Swedish school children. Acta Paediatr Scand (1987) 1.12
Nasal metachromatic cells in infancy in relation to the appearance of atopic disease during the first 6 years of life. Allergy (1997) 1.12
Risk factors for respiratory symptoms and atopic sensitisation in the Baltic area. Arch Dis Child (1995) 1.11
Neutropenia induced by systemic infusion of lactoferrin. J Lab Clin Med (1982) 1.11
Distinct pattern of commensal gut microbiota in toddlers with eczema. Int Arch Allergy Immunol (2006) 1.10
Regulation of T-helper cell responses to inhalant allergen during early childhood. Clin Exp Allergy (1999) 1.09
Apically exposed, tight junction-associated beta1-integrins allow binding and YopE-mediated perturbation of epithelial barriers by wild-type Yersinia bacteria. Infect Immun (2000) 1.09
Atopic sensitization and respiratory symptoms among Polish and Swedish school children. Clin Exp Allergy (1994) 1.08
Influence of body mass on cross-country ski racing performance. Med Sci Sports Exerc (1992) 1.06
Localization of the Yersinia PTPase to focal complexes is an important virulence mechanism. Mol Microbiol (1999) 1.06
International variation in prevalence of rhinitis and its relationship with sensitisation to perennial and seasonal allergens. Eur Respir J (2008) 1.05
Total and allergen-specific immunoglobulin A levels in saliva in relation to the development of allergy in infants up to 2 years of age. Clin Exp Allergy (2002) 1.04
Appearance of IgE antibodies to ingested and inhaled allergens during the first 12 years of life in atopic and non-atopic children. Pediatr Allergy Immunol (1993) 1.03
High body mass index, asthma and allergy in Swedish schoolchildren participating in the International Study of Asthma and Allergies in Childhood: Phase II. Acta Paediatr (2003) 1.01
Kinetics for the inhibition of acetylcholinesterase from the electric eel by some organophosphates and carbamates. Eur J Biochem (1984) 1.01
Limiting factors in bacterial phagocytosis by human polymorphonuclear leukocytes. Acta Pathol Microbiol Scand C (1977) 1.01
Cat (Fel d I), dog (Can f I), and cockroach allergens in homes of asthmatic children from three climatic zones in Sweden. Allergy (1994) 1.01
The gut microbiota and its role in the development of allergic disease: a wider perspective. Clin Exp Allergy (2015) 1.01
Decreased serum factor B concentration associated with decreased opsonization of Escherichia coli in the idiopathic nephrotic syndrome. Pediatr Res (1977) 1.00
Extracellular release of reactive oxygen species from human neutrophils upon interaction with Escherichia coli strains causing renal scarring. Infect Immun (1991) 0.98
Chemoattractant factors in breast milk from allergic and nonallergic mothers. Pediatr Res (2000) 0.98
Adverse reactions to food and food allergy in young children in Iceland and Sweden. Scand J Prim Health Care (1999) 0.97
Appearance of atopic disease in relation to serum IgE antibodies in children followed up from birth for 4 to 15 years. J Allergy Clin Immunol (1994) 0.97
Translation of questions: the International Study of Asthma and Allergies in Childhood (ISAAC) experience. Int J Tuberc Lung Dis (2009) 0.96
Clinical symptoms and IgE responses to common food proteins and inhalants in the first 7 years of life. Clin Allergy (1987) 0.96
Effect of maternal avoidance of eggs, cow's milk and fish during lactation upon allergic manifestations in infants. Clin Exp Allergy (1989) 0.96
Sensitizing ability of derivatives of picryl chloride after exposure of mice on the skin and in the lung. Int Arch Allergy Appl Immunol (1983) 0.95
Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines. Vaccine (1995) 0.95
Effect of cryopreservation on expression of Th1 and Th2 cytokines in blood mononuclear cells from patients with different cytokine profiles, analysed with three common assays: an overall decrease of interleukin-4. Cryobiology (2004) 0.95
Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague. Microb Pathog (1999) 0.95
International variations in associations of allergic markers and diseases in children: ISAAC Phase Two. Allergy (2009) 0.94